Dr Reddy's launches stomach, esophagus problems treatment drug in the US
SECTIONS
Last Updated: Feb 22, 2021, 12:37 PM IST
Share
Synopsis
Quoting IQVIA Health data, Dr Reddy's said the Prevacid brand and generic had US sales of approximately USD 87 million for the most recent 12 months ending in December 2020.
Agencies
Representative Image
Drug major Dr Reddy's Laboratories on Monday said it has launched Lansoprazole delayed release orally disintegrating tablets, used to treat certain stomach and esophagus problems, in the US market. The product is a therapeutic equivalent generic version of Prevacid SoluTab delayed release orally disintegrating tablets approved by the US Food and Drug Administration (USFDA).